Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. esp. cir. oral maxilofac ; 41(3): 99-108, jul.-sept. 2019. ilus, tab, graf
Artigo em Inglês | IBECS | ID: ibc-191772

RESUMO

OBJECTIVE: Retrospective descriptive study of 21 oral soft tissue and/or maxillary bone metastatic cases. MATERIALS AND METHODS: Hospital records of our own department are reviewed for a 12-year period. Lymphoproliferative diseases, skin metastases, salivary glands, other craniofacial bones and cervical lymph-nodes are excluded. Epidemiologic, personal health, clinical, treatment and follow-up data are recollected and analysed in frequency statistics. RESULTS: Male:Female ratio is 1.3:1, year-old range 52-82 and ethnic group 100 % white-caucasian. 19.0 % have carcinogenic occupational exposure, 52.4 % tobacco abuse, 61.9 % some kind of alcohol use, 57.1 % cardiovascular risk, 19.0 % cardiologic records, 28.6 % pulmonary, 19.0 % gastrointestinal, 19.0 % endocrine, 14.3 % genitourinary, 9.5 % other primary malignancy and 23.8% a first-degree relative with a neoplasm. 33.3 % patients have taken osteonecrosisrelated drugs or received craniofacial radiotherapy. Metastasis is the debut in 7 patients while it corresponds to infirmity progression in 14. The chief reason for consultation is a mass. 8 lesions affect soft tissue and 13 the bone. 81.0 % have epithelial neoplasm lineages. The organ of origin is: 23.8 % lung, 23.8 breast, 23.8 % kidney, 9.5 % skin, 9.5 % soft parts, 4.8 % prostate and 4.8 % thyroid. 100 % have other location metastases. 14.3 % patients undergo surgery, 38.1 % receive radiotherapy, 47.6 % chemo- or targeted therapy, and 28.6 % symptomatic treatment. After a 1-124 months range of followup, 17 patients die and 4 are alive. CONCLUSIONS: Craniomaxillofacial metastases, usually with multiple visceral or axial skeleton lesions, have an ominous prognosis. Multidisciplinary management could benefit the patient status and lead to more favourable outcomes. There are exceptional cases of long-term survival


OBJETIVO: Estudio descriptivo retrospectivo de 21 casos de metástasis en tejidos blandos orales y/o huesos maxilares. MATERIAL Y MÉTODOS: Revisión a 12 años de actas de nuestro departamento, excluyendo procesos linfoproliferativos, metástasis cutáneas, glándulas salivales, otros huesos craneofaciales y ganglios cervicales. Se recopilan datos epidemiológicos, antecedentes, clínicos, tratamiento y seguimiento, y analizan mediante estadísticos de frecuencia. RESULTADOS: La proporción varón:mujer es 1,3:1, entre 52-82 años y todos de etnia blancocaucásica. El 19,0 % tiene exposición laboral carcinógena, el 52,4 % tabaquismo, el 61,9 % consumo de alcohol, el 57,1 % riesgo cardiovascular, el 19,0 % patología cardiaca, el 28,6 % pulmonar, el 19 % gastrointestinal, el 19 % endocrina, el 14,3 % genitourinaria, el 9,5 % otro tumor maligno primario y el 23,8 % un familiar de primer grado con una neoplasia, el 33,3 % ha tomado fármacos asociados a osteonecrosis o recibido radioterapia craneofacial. Siete pacientes debutan con la metástasis y 14 como progresión de neoplasia conocida. El motivo de consulta principal es una masa. Ocho lesiones afectan a tejidos blandos y 13 al hueso. El 81 % son tumores de estirpe epitelial. El origen es: 23,8 % pulmón, 23,8 % mama, 23,8 % renal, 9,5 % piel, 9,5 % partes blandas, 4,8 % próstata y 4,8 % tiroides. El 100 % tiene metástasis en otras localizaciones. El 14,3% pacientes son tratados con cirugía, el 38,1 % con radioterapia, el 47,6 % con quimioterapia dirigida, y el 28,6 % con tratamiento sintomático. 17 pacientes fallecidos y 4 vivos con rango 1-124 meses de seguimiento. CONCLUSIONES: Las metástasis craneomaxilofaciales, habitualmente con múltiples lesiones viscerales o en esqueleto axial, tienen pronóstico infausto. El manejo multidisciplinar podría beneficiar el estado basal del paciente y llevar a mejores resultados: Existen casos excepcionales de supervivencia a largo plazo


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Neoplasias Maxilares/patologia , Metástase Neoplásica/patologia , Osteonecrose/patologia , Metástase Neoplásica/terapia , Resultado do Tratamento , Prognóstico , Estudos Retrospectivos , Diagnóstico Diferencial
2.
Cardiovasc Pathol ; 26: 7-11, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27835822

RESUMO

Woven coronary artery is a rare anomaly characterized by thin channels arising from the coronary artery and reanastomosing at the distal arterial segment. To our knowledge, no data are available currently on the histologic structure of the woven segment. A 39-year-old man presented with sudden atypical chest pain while he was practicing cycling. During the transfer of the patient to the hospital, he suffered cardiac arrest. After 50 min of cardiopulmonary resuscitation, the patient could not return to sinus rhythm and died. At autopsy, the patient presented a woven right coronary artery associated with an old myocardial infarct of the posterior wall of the left ventricle. We describe for the first time a case of woven coronary artery associated with sudden death. This case allowed us to study the histopathology of the channels that make up the malformation. These showed well-conformed walls with absence of breaches. A complete review of the literature on the subject is included.


Assuntos
Anomalias dos Vasos Coronários/complicações , Anomalias dos Vasos Coronários/patologia , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/patologia , Adulto , Humanos , Masculino
3.
Anticancer Drugs ; 23 Suppl: S10-2, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22739665

RESUMO

We report the case of a 62-year-old woman who presented to the emergency department with abdominal pain and distension. She was diagnosed with haemoperitoneum and a large tumour that occupied the entire left hypochondrium and attached to the posterior surface of the fundus of the stomach at the level of the greater curvature. Anatomical pathology examination identified the tumour as a gastrointestinal stromal tumour with highly malignant characteristics and the haemoperitoneum was considered to contribute to a worse prognosis because of its ability to produce a peritoneal seeding. Considering these adverse characteristics, imatinib was initiated as an adjuvant treatment, with no evidence of relapse in the follow-up.


Assuntos
Neoplasias Gastrointestinais/diagnóstico por imagem , Tumores do Estroma Gastrointestinal/diagnóstico por imagem , Hemoperitônio/diagnóstico por imagem , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Benzamidas , Quimioterapia Adjuvante , Feminino , Neoplasias Gastrointestinais/tratamento farmacológico , Neoplasias Gastrointestinais/patologia , Neoplasias Gastrointestinais/cirurgia , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Tumores do Estroma Gastrointestinal/patologia , Tumores do Estroma Gastrointestinal/cirurgia , Hemoperitônio/tratamento farmacológico , Hemoperitônio/patologia , Hemoperitônio/cirurgia , Humanos , Mesilato de Imatinib , Pessoa de Meia-Idade , Piperazinas/administração & dosagem , Piperazinas/uso terapêutico , Pirimidinas/administração & dosagem , Pirimidinas/uso terapêutico , Ruptura Espontânea , Tomografia Computadorizada por Raios X , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...